# Kyntra Bio, Inc.: Form 8-K, filed Dec 16, 2024

- Company: [Kyntra Bio, Inc.](/companies/kynb.md) (CIK 921299)
- Form: 8-K
- Filed: 2024-12-16
- Accepted by EDGAR: Dec 16, 2024, 14:15 ET
- Period: 2024-12-16
- Accession: 0000950170-24-136408
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921299/000095017024136408/fgen-20241216.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921299/000095017024136408/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921299/000095017024136408/fgen-20241216.htm

Filed Dec 16, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-136408. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.